UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Trends in US hospital admissions for skin and soft tissue infections

Emerging infectious diseases, 2009-09, Vol.15 (9), p.1516-1518

2009

Volltextzugriff (PDF)

Economic Burden of Adverse Events in Patients With Metastatic Renal Cell Carcinoma

Clinical therapeutics, 2013-12, Vol.35 (12), p.1955-1963.e2

2013

Volltextzugriff (PDF)

Pharmacotherapy patterns in patients with chronic idiopathic constipation beginning treatment with linaclotide or lubiprostone in the United States

Drugs in Context, 2020, Vol.9, p.1-7

2020

Volltextzugriff (PDF)

Systematic review and meta-analysis of efficacy, safety, and tolerability data from randomized controlled trials of drugs used to treat postherpetic neuralgia

The Annals of pharmacotherapy, 2011-12, Vol.45 (12), p.1483-1490

2011

Volltextzugriff (PDF)

Impact of Elexacaftor/Tezacaftor/Ivacaftor on Healthcare Resource Utilization and Associated Costs Among People With Cystic Fibrosis in the US: A Retrospective Claims Analysis

Pulmonary therapy, 2023-12, Vol.9 (4), p.479-498

2023

Volltextzugriff (PDF)

Healthcare costs in patients with metastatic lung cancer receiving chemotherapy

BMC health services research, 2011-11, Vol.11 (1), p.305-305, Article 305

2011

Volltextzugriff (PDF)

Cost-Effectiveness of Adult Universal Hepatitis B Vaccination

The Journal of infectious diseases, 2022-12, Vol.226 (12), p.2239-2241

2022

Volltextzugriff (PDF)

Utilization and Cost in Clinical Practice of Darbepoetin Alfa and Epoetin Alfa for Anemia Concomitant With Chemotherapy

Clinical therapeutics, 2012-06, Vol.34 (6), p.1350-1363

2012

Volltextzugriff (PDF)

Clinical staging in amyotrophic lateral sclerosis: analysis of Edaravone Study 19

Journal of neurology, neurosurgery and psychiatry, 2021-02, Vol.92 (2), p.165-171

2021

Volltextzugriff (PDF)

737 Economic Burden of Biologic Treatment in Patients With Inflammatory Bowel Disease in the U.S

The American journal of gastroenterology, 2019-10, Vol.114 (1), p.S433-S434

2019

Volltextzugriff (PDF)

2920 Prior Pharmacotherapy Patterns Among Patients With IBD in the USA Initiating Biologic Therapy

The American journal of gastroenterology, 2019-10, Vol.114 (1), p.S1593-S1593

2019

Volltextzugriff (PDF)

738 Current Treatment Patterns Among Patients With IBD in the U.S. Initiating Biologic Therapy

The American journal of gastroenterology, 2019-10, Vol.114 (1), p.S434-S434

2019

Volltextzugriff (PDF)

Adult immunization against hepatitis B: Does the number of jabs matter?

Vaccine, 2022-06, Vol.40 (26), p.3597-3604

2022

Volltextzugriff (PDF)

Mo1573 - Patterns of Pharmacotherapy in Patients with Chronic Idiopathic Constipation Initiating Treatment with Linaclotide or Lubiprostone

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-757-S-757

2018

Volltextzugriff (PDF)

Venous thromboembolism following major orthopedic surgery: review of epidemiology and economics

American journal of health-system pharmacy, 2001-11, Vol.58 (suppl 2), p.S4-S13

2001

Volltextzugriff (PDF)

Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma : Risk factors and clinical consequences

Cancer, 2006-01, Vol.106 (2), p.329-336

2006

Volltextzugriff (PDF)

Economic Costs of Nonmedical Use of Prescription Opioids

The Clinical journal of pain, 2011-03, Vol.27 (3), p.194-202

2011

Volltextzugriff (PDF)

Post-hoc analyses of an Edaravone Controlled Clinical Trial Suggest Similar Rates of Decline in King’s Amyotrophic Lateral Sclerosis (ALS) Clinical Staging across Subgroups (P6.464)

Neurology, 2018-04, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

1639: TIME BELOW MAP THRESHOLD IN FIRST 24 HOURS OF INITIATION OF VASOPRESSOR THERAPY AND MORTALITY

Critical care medicine, 2019-01, Vol.47 (1), p.794-794

2019

Volltextzugriff (PDF)

A pragmatic randomized clinical trial of insulin glargine 300 U/mL vs first‐generation basal insulin analogues in insulin‐naïve adults with type 2 diabetes: 6‐month outcomes of the ACHIEVE Control study

Diabetes, obesity & metabolism, 2020-11, Vol.22 (11), p.2004-2012

2020

Volltextzugriff (PDF)

Cover Image, Volume 22, Issue 11

Diabetes, obesity & metabolism, 2020-11, Vol.22 (11)

2020

Volltextzugriff (PDF)

A pragmatic randomized clinical trial of insulin glargine 300U/mL vs first‐generation basal insulin analogues in insulin‐naïve adults with type 2 diabetes: 6‐month outcomes of the ACHIEVE Control study

Diabetes, obesity & metabolism, 2020-11, Vol.22 (11), p.2004-2012

2020

Volltextzugriff (PDF)

Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs

Journal of the American College of Cardiology, 2001-05, Vol.37 (6), p.1692-1699

2001

Volltextzugriff (PDF)

Cost effectiveness of carvedilol for heart failure

The American journal of cardiology, 1999-03, Vol.83 (6), p.890-896

1999

Volltextzugriff (PDF)

Economic burden of adverse events in patients with metastatic renal cell carcinoma (mRCC)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e16573-e16573

2012

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(88)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Trends in US hospital admissions for skin and soft tissue infections

Economic Burden of Adverse Events in Patients With Metastatic Renal Cell Carcinoma

Pharmacotherapy patterns in patients with chronic idiopathic constipation beginning treatment with linaclotide or lubiprostone in the United States

Systematic review and meta-analysis of efficacy, safety, and tolerability data from randomized controlled trials of drugs used to treat postherpetic neuralgia

Impact of Elexacaftor/Tezacaftor/Ivacaftor on Healthcare Resource Utilization and Associated Costs Among People With Cystic Fibrosis in the US: A Retrospective Claims Analysis

Healthcare costs in patients with metastatic lung cancer receiving chemotherapy

Cost-Effectiveness of Adult Universal Hepatitis B Vaccination

Utilization and Cost in Clinical Practice of Darbepoetin Alfa and Epoetin Alfa for Anemia Concomitant With Chemotherapy

Clinical staging in amyotrophic lateral sclerosis: analysis of Edaravone Study 19

737 Economic Burden of Biologic Treatment in Patients With Inflammatory Bowel Disease in the U.S

2920 Prior Pharmacotherapy Patterns Among Patients With IBD in the USA Initiating Biologic Therapy

738 Current Treatment Patterns Among Patients With IBD in the U.S. Initiating Biologic Therapy

Adult immunization against hepatitis B: Does the number of jabs matter?

Mo1573 - Patterns of Pharmacotherapy in Patients with Chronic Idiopathic Constipation Initiating Treatment with Linaclotide or Lubiprostone

Venous thromboembolism following major orthopedic surgery: review of epidemiology and economics

Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma : Risk factors and clinical consequences

Economic Costs of Nonmedical Use of Prescription Opioids

Post-hoc analyses of an Edaravone Controlled Clinical Trial Suggest Similar Rates of Decline in King’s Amyotrophic Lateral Sclerosis (ALS) Clinical Staging across Subgroups (P6.464)

1639: TIME BELOW MAP THRESHOLD IN FIRST 24 HOURS OF INITIATION OF VASOPRESSOR THERAPY AND MORTALITY

A pragmatic randomized clinical trial of insulin glargine 300 U/mL vs first‐generation basal insulin analogues in insulin‐naïve adults with type 2 diabetes: 6‐month outcomes of the ACHIEVE Control study

Cover Image, Volume 22, Issue 11

A pragmatic randomized clinical trial of insulin glargine 300U/mL vs first‐generation basal insulin analogues in insulin‐naïve adults with type 2 diabetes: 6‐month outcomes of the ACHIEVE Control study

Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs

Cost effectiveness of carvedilol for heart failure

Economic burden of adverse events in patients with metastatic renal cell carcinoma (mRCC)

Aktive Filter

Suchergebnisse filtern